-
Dr. Scott Gottlieb recently spoke to the International Society for Stem Cell Research in Berkeley, California, to address how the FDA needs to adapt its approach to pre-market regulations of novel areas of technology -- such as gene therapy -- focusing on measures of risk rather than clinical applications.
-
Heart disease and stroke research has received funding through the recently passed spending bill. The National Institute of Neurological Disorders and Stroke will receive $91 million in financial support from the federal government, and the National Heart, Lung and Blood Institute will get $118 million.